Medicare Enrolled
Dr. Juan Masi, MD
Internal Medicine · North Port, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Masi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Masi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Masi
Dr. Juan Masi is an internal medicine in North Port, FL, with 19 years in practice. Based on federal Medicare data, Dr. Masi performed 14,726 Medicare services across 8,748 unique beneficiaries.
Between the years covered by Open Payments, Dr. Masi received a total of $16,879 from 58 pharmaceutical and/or device companies across 985 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Masi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in FL$ $16,879 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,726
Medicare services
Top 2% in FL for internal medicine
8,748
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~775 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $25 |
| Joint lubricant injection (Synvisc) | 1,440 | $7 | $21 |
| Office visit, established patient (30-39 min) | 1,306 | $90 | $155 |
| Blood draw (venipuncture) | 900 | $8 | $14 |
| Comprehensive metabolic blood panel | 529 | $10 | $26 |
| Complete blood count (CBC) with differential | 527 | $8 | $18 |
| Thyroid stimulating hormone (TSH) test | 487 | $16 | $41 |
| Free thyroxine (T4) test | 485 | $9 | $22 |
| Thyroid hormone, t3 measurement, free | 485 | $17 | $40 |
| Automated urinalysis | 480 | $2 | $6 |
| Annual wellness visit, follow-up | 390 | $125 | $180 |
| Annual depression screening | 366 | $18 | $31 |
| Hemoglobin A1c test (diabetes monitoring) | 351 | $9 | $24 |
| Office visit, established patient, complex (40-54 min) | 351 | $129 | $210 |
| Urine microalbumin (protein) analysis | 336 | $6 | $11 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 321 | $41 | $75 |
| Cholesterol level | 314 | $4 | $11 |
| Office visit, established patient (20-29 min) | 257 | $65 | $105 |
| Drug injection, under skin or into muscle | 240 | $10 | $35 |
| Ceftriaxone antibiotic injection | 208 | $0 | $12 |
| Uric acid level test | 186 | $4 | $12 |
| Vitamin B-12 level test | 185 | $15 | $37 |
| Folic acid level test | 184 | $14 | $36 |
| Magnesium level test | 184 | $7 | $17 |
| Iron level test | 182 | $6 | $16 |
| Electrocardiogram (EKG), 12-lead | 181 | $11 | $33 |
| Ferritin level test (iron stores) | 180 | $13 | $33 |
| Vitamin D level test | 178 | $29 | $72 |
| Parathyroid hormone level test | 178 | $40 | $99 |
| Phosphate level test | 177 | $5 | $12 |
| Lipid panel (cholesterol and triglycerides) | 174 | $13 | $33 |
| Injection, zoledronic acid, 1 mg | 105 | $7 | $25 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 101 | $15 | $30 |
| Injection, methylprednisolone acetate, 80 mg | 94 | $9 | $17 |
| Ultrasound of both sides of head and neck blood flow | 88 | $132 | $406 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 85 | $49 | $93 |
| Testosterone (hormone) level, total | 81 | $25 | $63 |
| Prothrombin time test (blood clotting) | 78 | $4 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 65 | $49 | $115 |
| Prostate cancer screening; prostate specific antigen test (psa) | 63 | $19 | $46 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 54 | $76 | $160 |
| Stool analysis for blood to screen for colon tumors | 41 | $5 | $8 |
| Transitional care management services for problem of high complexity | 40 | $214 | $415 |
| Complete ultrasound scan of abdomen | 35 | $73 | $231 |
| Transitional care management services for problem of at least moderate complexity | 35 | $158 | $315 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 34 | $40 | $121 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 32 | $88 | $200 |
| Joint injection, major joint | 31 | $47 | $117 |
| Urinalysis, manual | 31 | $3 | $6 |
| PSA test (prostate cancer screening) | 28 | $18 | $45 |
| Natriuretic peptide (heart and blood vessel protein) level | 27 | $37 | $84 |
| Complete ultrasound scan behind abdominal cavity | 24 | $72 | $225 |
| New patient office visit (45-59 min) | 20 | $111 | $240 |
| Ultrasound of leg arteries or artery grafts | 19 | $181 | $479 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $290 | $740 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $47 | $177 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $28 | $92 |
| Test to determine lung volumes using gas dilution or washout | 16 | $31 | $51 |
| Test to examine how well the lungs exchange gases | 16 | $42 | $65 |
| Flu vaccine administration | 14 | $30 | $34 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 14 | $162 | $270 |
| Flu vaccine, quadrivalent | 13 | $72 | $101 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 12 | $70 | $137 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
27.2% medium
72.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,879
Total received (2018-2024)
Avg $2,411/year across 7 years
Top 4% in FL for internal medicine
58
Companies
985
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,879 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,705
2023$2,942
2022$2,758
2021$2,588
2020$1,824
2019$2,047
2018$2,015
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,727
AstraZeneca Pharmaceuticals LP
$1,394
Lilly USA, LLC
$1,126
GlaxoSmithKline, LLC.
$1,091
Amgen Inc.
$779
PFIZER INC.
$744
Novartis Pharmaceuticals Corporation
$707
Radius Health, Inc.
$678
Kowa Pharmaceuticals America, Inc.
$617
Boehringer Ingelheim Pharmaceuticals, Inc.
$610
ABBVIE INC.
$542
Esperion Therapeutics, Inc.
$525
SANOFI-AVENTIS U.S. LLC
$512
Bayer Healthcare Pharmaceuticals Inc.
$459
E.R. Squibb & Sons, L.L.C.
$416
Merck Sharp & Dohme Corporation
$408
Astellas Pharma US Inc
$400
Bayer HealthCare Pharmaceuticals Inc.
$326
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$318
Takeda Pharmaceuticals U.S.A., Inc.
$272
Vanda Pharmaceuticals Inc.
$259
Janssen Pharmaceuticals, Inc
$247
Amarin Pharma Inc.
$236
Antares Pharma, Inc.
$235
Xeris Pharmaceuticals, Inc.
$225
Abbott Laboratories
$177
AbbVie, Inc.
$177
Dexcom, Inc.
$163
Almatica Pharma LLC
$145
AbbVie Inc.
$141
Boston Scientific Corporation
$138
Neurocrine Biosciences, Inc.
$125
Merck Sharp & Dohme LLC
$123
Sunovion Pharmaceuticals Inc.
$115
Amneal Pharmaceuticals LLC
$85
Horizon Therapeutics plc
$72
Supernus Pharmaceuticals, Inc.
$55
Regeneron Healthcare Solutions, Inc.
$43
ARBOR PHARMACEUTICALS, INC.
$41
Phathom Pharmaceuticals, Inc.
$38
Mylan Specialty L.P.
$38
Biohaven Pharmaceuticals, Inc.
$37
Biohaven Pharmaceutical Holding Company Ltd.
$36
Circassia Pharmaceuticals Inc
$35
Allergan Inc.
$26
Nestle HealthCare Nutrition Inc.
$25
Zyla Life Sciences
$23
SANOFI PASTEUR INC.
$22
Corcept Therapeutics
$20
Genentech USA, Inc.
$17
Eisai Inc.
$16
IBSA Pharma Inc.
$16
DEXCOM, INC.
$16
Adlon Therapeutics L.P.
$14
IDORSIA PHARMACEUTICALS US INC
$14
Cleerly, Inc.
$14
Aytu BioScience, Inc
$13
FIDIA PHARMA USA INC.
$9
Top 3 companies account for 25.2% of total payments
Associated products mentioned in payments ›
ADACEL · ADHANSIA XR · AIRSUPRA · ANORO · ANORO ELLIPTA · Aimovig · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BYSTOLIC · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cleerly Ischemia · Creon · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVKEEZA · EVUSHELD · Edarbi · Edarbyclor · FARXIGA · FASENRA · FLECTOR · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GRALISE · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · Horizant · Hymovis · INGREZZA · INVEGA SUSTENNA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · MitraClip System · Myrbetriq · NEXLETOL · NOCDURNA · NURTEC ODT · Natesto · OTREXUP · Otezla · Ozempic · PENNSAID · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Perforomist · Prolia · QULIPTA · QUVIVIQ · RAYOS · RYBELSUS · RYTARY · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SIVEXTRO · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SPRIX · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Seglentis · TLANDO · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · VESICARE · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN · WATCHMAN FLX · XARELTO · XIFAXAN · XYOSTED · Xofluza · YUPELRI · ZENPEP · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in FL.
Equivalent to $115 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
347
Per 100K population
77.3
County median income
$80,633
Nearest hospital
HCA FLORIDA ENGLEWOOD HOSPITAL
7.5 mi
7.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Masi is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Masi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Masi performed 1,620 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Masi receive payments from pharmaceutical companies?
Yes. Dr. Masi received a total of $16,879 from 58 companies across 985 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Masi's costs compare to other internal medicines in North Port?
Dr. Masi's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Masi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in North Port
Browse internal medicines in North Port ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in FL
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in FL
Which FL internal medicines receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology